miR-184 represses β-catenin and behaves as a skin tumor suppressor.

Autor: Turovsky L; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel.; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel., Kheshaiboun G; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel.; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel., Yassen G; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Nagosa S; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Boyango I; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel., Amitai-Lange A; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Bhattacharya S; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Ilan N; Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, 31096, Israel., Vlodavsky I; Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, 31096, Israel., Aberdam D; Université de Paris Cité, INSERM U1138, Centre des Cordeliers, Paris, France., Shalom-Feuerstein R; Department of Genetics & Developmental Biology, The Rappaport Faculty of Medicine & Research Institute, Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, 31096, Israel., Avitan-Hersh E; Skin Cancer Research lab, Clinical research institute (CRIR), Rambam Health Care Campus, Haifa, 31096, Israel. emily@technion.ac.il.; Cell Biology and Cancer Science, The Ruth and Bruce Rappaport Faculty of Medicine, Technion Integrated Cancer Center, Technion Israel Institute of Technology, Haifa, 31096, Israel. emily@technion.ac.il.

Publikováno v: Cell death & disease [Cell Death Dis] 2024 Feb 26; Vol. 15 (2), pp. 174. Date of Electronic Publication: 2024 Feb 26.

A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.

Autor: Golan S; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel., Bar V; Curesponse, Rehovot, Israel., Salpeter SJ; Curesponse, Rehovot, Israel., Neev G; Curesponse, Rehovot, Israel., Creiderman G; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel., Kedar D; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel., Aharon S; Curesponse, Rehovot, Israel., Turovsky L; Curesponse, Rehovot, Israel., Zundelevich A; Curesponse, Rehovot, Israel., Shahar H; Curesponse, Rehovot, Israel., Shapira H; Curesponse, Rehovot, Israel., Mallel G; Curesponse, Rehovot, Israel., Stossel E; Curesponse, Rehovot, Israel., Gavert N; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel., Straussman R; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel., Dotan Z; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Berger R; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Stossel C; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Golan T; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Halperin S; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Leibovici D; Department of Urology, Kaplan Medical Center, Rehovot, Israel., Breuer S; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Rottenberg Y; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Applebaum L; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Hubert A; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Nechushtan H; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Peretz T; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Zick A; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Chertin B; Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel., Koulikov D; Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel., Sonnenblick A; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Rosenbaum E; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2023 Sep 28; Vol. 10, pp. 1221484. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023).

579 miR-184 represses stemness and behaves as a tumor suppressor in the epidermis

Autor: Turovsky, L., Nagosa, S., Boyango, I., Bhattacharya, S., Vlodavsky, I., Aberdam, D., Emily Avitan-Hersh, E., Shalom-Feuerstein, R.

Publikováno v: In Journal of Investigative Dermatology May 2021 141(5) Supplement:S100-S100

The uncertainty of carbon dioxide determination in gaseous mixtures

Autor: Kuselman, I., Anisimov, B., Turovsky, L., Shenhar, A.

Publikováno v: Analytica Chimica Acta; 1996, Vol. 318 Issue: 3 p327-333, 7p

РОЗРОБКА АЛГОРИТМІВ ОПТИМАЛЬНОГО ПРИЙОМУ СИГНАЛІВ ІЗ ФАЗОРІЗНИЦЕВОЮ МОДУЛЯЦІЄЮ ВИСОКОЇ КРАТНОСТІ. (Ukrainian)

Autor: Дакова, Лариса, Даков, Сергій, Блаженний, Назарій

Publikováno v: Ukrainian Scientific Journal of Information Security; 2024, Vol. 30 Issue 1, p46-50, 5p